Blog
85% of Patients With NRAS-Mutated Melanoma Achieved a Complete Response With This Treatment
Combined talimogene laherparepvec and binimetinib in patients with NRAS-mutated melanoma induces anti-tumor immunity
Engineered T Cells Put 17-Year-Old With Advanced Cancer Into Complete Remission
The patient receiving T-cell therapy against PRAME in July 2025. Courtesy of Hopp Children’s Cancer Center
Fecal Microbiome Transplant Clinical Trials
A list compiled of fecal transplant clinical trials available as of 7/27/2026.
Leptomeningeal Disease (LMD) Resources
These are the most valuable lessons I have learned over the past year — things I wish I knew from day one.